Intra-Cellular Therapies Share Holder Equity 2013-2024 | ITCI

Intra-Cellular Therapies share holder equity for the quarter ending September 30, 2024 was $1.145B, a 90.59% increase year-over-year.

  • Intra-Cellular Therapies share holder equity for 2023 was $0.591B, a 9.85% decline from 2022.
  • Intra-Cellular Therapies share holder equity for 2022 was $0.656B, a 57% increase from 2021.
  • Intra-Cellular Therapies share holder equity for 2021 was $0.418B, a 36.38% decline from 2020.

Intra-Cellular Therapies Share Holder Equity 2013-2024 | ITCI

  • Intra-Cellular Therapies share holder equity for 2023 was $0.591B, a 9.85% decline from 2022.
  • Intra-Cellular Therapies share holder equity for 2022 was $0.656B, a 57% increase from 2021.
  • Intra-Cellular Therapies share holder equity for 2021 was $0.418B, a 36.38% decline from 2020.